Exhibit
10.1


 


EXCHANGE
AGREEMENT


 


This
Exchange Agreement (the “Agreement”) is entered into as of this 20th day of November, 2020, by and
between ToughBuilt Industries, Inc., a Nevada corporation with offices located at 25371 Commercentre Drive, Suite 200, Lake Forest,
CA 92630 (the “Company”), and the Holder signatory hereto (the “Holder”), with reference
to the following facts:


 


A.
Prior to the date hereof, (i) pursuant to that certain Securities Purchase Agreement, dated as of August 19, 2019, by and between
the Company and the investors party thereto (as amended, the “Securities Purchase Agreement”), the Company
issued to such investors, among other things, (x) Series A Notes (as defined in the Securities Purchase Agreement), (y) Series
B Notes (as defined in the Securities Purchase Agreement), in accordance with the terms thereof and (z) the Warrants (as defined
in the Securities Purchase Agreement). Capitalized terms used but not otherwise defined herein shall have the meanings as set
forth in the Securities Purchase Agreement (as amended hereby).


 


B.
As of the date hereof, (i) the Holder holds (A) such aggregate amount of Series A Notes as set forth on the signature page of
the Holder attached hereto (the “Existing Series A Note”), (B) such aggregate amount of Series B Notes (the
“Existing Series B Note,” and together with the Existing Series A Note, the “Existing Notes”)
with such Restricted Principal (as defined in the Existing Series B Note) and Unrestricted Principal (as defined in the Existing
Series B Note), in each case, as set forth on the signature page of the Holder attached hereto and (C) a Warrant exercisable into
such aggregate number of shares of Common Stock of the Company as set forth on the signature page of the Holder attached hereto
(without regard to any limitation on exercise set forth therein) (the “Existing Warrant,” and together with
the Existing Notes, the “Existing Securities”) and (ii) the Holder possesses, as collateral for the purchase
price of the Existing Series B Note, a secured promissory note, issued by the Holder to the Company pursuant to that certain Note
Purchase Agreement, dated August 19, 2019, between the Company and the Holder, in such aggregate principal as set forth on the
signature page of the Holder attached hereto (the “Existing Investor Note”).


 


C.
The Company has authorized a new series of Preferred Stock of the Company designated as Series E Preferred Stock, $0.0001 par
value, the terms of which are set forth in the certificate of designation for such series of Preferred Stock (the “Series
E Certificate of Designation”) in the form attached hereto as Exhibit A (together with any shares of Series
E Preferred Stock issued in replacement thereof in accordance with the terms thereof, the “Series E Preferred Stock”).


 


D.
The Company and the Holder desire to, on the basis and subject to the terms and conditions set forth in this Agreement, (i) after
giving effect to the Waiver (as defined in Section 1 below), permit the Company to effect a Company Optional Redemption of $1,480,000
of the Restricted Principal of the Existing Series B Note (the “Restricted Note”) in a Redemption Netting (as
defined in the Existing Series B Note) (the “Note Redemption”), (ii) after giving effect to the Note Redemption,
exchange (the “Exchange,” and together with the Note Redemption, the “Transactions”) the
remaining Existing Securities for (A) such aggregate number of shares of Series E Preferred Stock as set forth on the signature
page of the Holder attached hereto (the “New Preferred Shares”), (B) a cash payment by the Company to the Holder
on the date hereof of $744,972 (the “Company Cash Exchange Payment”), (C) such aggregate number of shares of
Common Stock as set forth on the signature page of the Holder attached hereto (the “New Common Shares”), which
shall not bear any restrictive legend and (D) a warrant to purchase Common Stock (the “New Warrant”) in the
form attached hereto as Exhibit B, initially exercisable into such aggregate number of shares of Common Stock as set forth
on the signature page of the Holder attached hereto (the “New Warrant Shares,” and together with the New Common
Shares, the “New Shares”). The New Preferred Shares, the New Warrants and the New Common Shares are referred
to herein as the “New Primary Securities,” and together with the New Warrant Shares, the “New Securities.”
The New Securities and this Agreement and such other documents and certificates related thereto are collectively referred to herein
as the “Exchange Documents.”


 




    	 



     


    

 


E.
The Exchange is being made in reliance upon the exemption from registration requirements of the Securities Act of 1933, as amended
(the “1933 Act”), provided by Section 3(a)(9) promulgated thereunder.


 


NOW,
THEREFORE, in consideration of the foregoing premises and the mutual covenants hereinafter contained, the sufficiency of which
is acknowledged by the parties, the parties hereto agree as follows:


 


1.
Waiver; Note Redemption. Effective as of the Effective Time (as defined in Section 3(c) below), the Holder hereby
waives any term or condition in the Series B Note necessary to permit and effect the Note Redemption as of the Effective Time,
including, without limitation, any premium otherwise payable thereunder, notice requirements and the termination of any prior
waiver by the Company of its right to effect a Company Optional Redemption with respect to the Restricted Note (the “Waiver”).
The parties hereto acknowledge and agree that as of the Effective Time, both the Restricted Note and the Investor Note shall be
subject to a Company Optional Redemption and Redemption Netting and shall thereafter both be deemed satisfied in full and cancelled
and the Holder shall release and discharge the Company from all of its obligations under the Restricted Note and the Company shall
release and discharge the Holder from all of its obligations under the Investor Note.


 


2.
Exchange. Immediately following the Effective Time and the consummation of the Note Redemption, with respect to
the consummation of the Exchange pursuant to Section 3(a)(9) of the 1933 Act, (a) the Holder hereby conveys, assigns and transfers
the Existing Securities to the Company in exchange for which the Company agrees to issue the New Primary Securities to the Holder
below and (b) in exchange for the Existing Securities, the Company shall issue and deliver the New Primary Securities to the Holder
and make the Payments (as defined in Section 3(b) below) in accordance with Section 3(b) below. The Holder acknowledges that,
after the consummation in full of the Transactions, the Existing Notes shall no longer remain outstanding and the Company is permitted
to file a UCC-3 termination statement with respect to any UCC-1 financing statement previously filed by the Holder with respect
thereto.


 




    	2



     


    




 


3.
Delivery of Securities; Cash Payments; Effective Time.


 


(a)
On or prior to the Effective Time, the Company shall deliver (the “Common Share Delivery”) the New Common Shares
to the Holder by deposit/withdrawal at custodian in accordance with the DWAC instructions on the signature page of the Holder,
which New Common Shares shall be issued without a securities laws restrictive legend and shall be freely tradable by the Holder
(assuming the Holder is not then an affiliate of the Company). Within five (5) Trading Days after the Effective Time, the Company
shall deliver the New Preferred Shares in certificate or book entry form and the New Warrant to the Holder. Notwithstanding the
foregoing, as of the Effective Time, the Holder shall be deemed for all corporate purposes to have become the holder of record
of the New Primary Securities and shall be entitled to exercise all of its rights with respect to the New Primary Securities and,
irrespective of the date the Company delivers such New Primary Securities.


 


(b)
On or prior to the Effective Time, the Company shall pay (the “Payment”), in U.S. dollars and immediately available
funds, the Cash Exchange Payment to the Holder in accordance with wire instructions set forth on the signature page of the Holder
attached hereto and the Legal Fee Amount (as defined below) to Kelley Drye & Warren LLP in accordance with wire instructions
attached hereto as Schedule 3(b).


 


(c)
This Agreement shall be deemed to be effective (the “Effective Time”) upon the later of (i) the time of full
execution and delivery by the parties hereto of this Agreement and the other Exchange Documents, (ii) the time of receipt of the
Payments and (iii) the time of consummation of the Common Share Delivery.


 


4.
Ratifications; Incorporation of Terms under Transaction Documents.


 


(a)
Ratifications. Except as otherwise expressly provided herein, the Securities Purchase Agreement, and each other Transaction
Document, is, and shall continue to be, in full force and effect and is hereby ratified and confirmed in all respects, except
that on and after the date hereof: (i) all references in the Securities Purchase Agreement to “this Agreement,” “hereto,”
“hereof,” “hereunder” or words of like import referring to the Securities Purchase Agreement shall mean
the Securities Purchase Agreement as amended by this Agreement, and (ii) all references in the other Transaction Documents to
the “Securities Purchase Agreement,” “thereto,” “thereof,” “thereunder” or words
of like import referring to the Securities Purchase Agreement shall mean the Securities Purchase Agreement as amended by this
Agreement and the Exchange Documents.


 


(b)
Amendments and Incorporation of Terms under Transaction Documents. Effective as of the Effective Time, the Securities Purchase
Agreement and each of the other Transaction Documents are hereby amended as follows (and any such agreements, covenants and related
provisions therein shall be deemed incorporated by reference herein, mutatis mutandis, as amended as such):


 


(i)
The defined term “Notes” is hereby amended to include the New Preferred Shares (as defined herein).


 




    	3



     


    




 


(ii)
The defined term “Warrants” is hereby amended to include the New Warrant (as defined herein).


 


(iii)
The defined term “Warrant Shares” is hereby amended to include the New Warrant Shares (as defined herein).


 


(iv)
The defined term “Transaction Documents” is hereby amended to include this Agreement and the Exchange Documents and
the Series E Certificate of Designation.


 


5.
Representations and Warranties. Except as set forth in the correspondingly numbered Section of the Disclosure Schedules,
the Company represents and warrants to Holder that the statements contained in this Section 5 are true and correct as of the date
hereof and will be at the Effective Time:


 


(a)
Organization and Qualification. Each of the Company and each of its Subsidiaries are entities duly organized and validly
existing and in good standing under the laws of the jurisdiction in which they are formed, and have the requisite power and authority
to own their properties and to carry on their business as now being conducted and as presently proposed to be conducted. Each
of the Company and each of its Subsidiaries is duly qualified as a foreign entity to do business and is in good standing in every
jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification necessary,
except to the extent that the failure to be so qualified or be in good standing would not reasonably be expected to have a Material
Adverse Effect (as defined below). As used in this Agreement, “Material Adverse Effect” means any material
adverse effect on (i) the business, properties, assets, liabilities, operations (including results thereof), condition (financial
or otherwise) or prospects of the Company or any Subsidiary, individually or taken as a whole, (ii) the transactions contemplated
hereby or in any of the other Exchange Documents or (iii) the authority or ability of the Company or any of its Subsidiaries to
perform any of their respective obligations under any of the Exchange Documents (as defined below). Other than the Persons (as
defined below) listed in the SEC Documents (as defined in Section 5(h) below), the Company has no Subsidiaries. “Subsidiaries”
means any Person in which the Company, directly or indirectly, (I) owns any of the outstanding capital stock or holds any equity
or similar interest of such Person or (II) controls or operates all or any part of the business, operations or administration
of such Person, and each of the foregoing, is individually referred to herein as a “Subsidiary.” For purposes
of this Agreement, (x) “Person” means an individual, a limited liability company, a partnership, a joint venture,
a corporation, a trust, an unincorporated organization, any other entity and any Governmental Entity or any department or agency
thereof and (y) “Governmental Entity” means any nation, state, county, city, town, village, district, or other
political jurisdiction of any nature, federal, state, local, municipal, foreign, or other government, governmental or quasi-governmental
authority of any nature (including any governmental agency, branch, department, official, or entity and any court or other tribunal),
multi-national organization or body; or body exercising, or entitled to exercise, any administrative, executive, judicial, legislative,
police, regulatory, or taxing authority or power of any nature or instrumentality of any of the foregoing, including any entity
or enterprise owned or controlled by a government or a public international organization or any of the foregoing.


 




    	4



     


    




 


(b)
Authorization and Binding Obligation. The Company has the requisite corporate power and authority to enter into and perform
its obligations under this Agreement and each of the other agreements entered into by the parties hereto in connection with the
transactions contemplated by the Exchange Documents and to consummate the Transactions (including, without limitation, the issuance
of the New Primary Securities in accordance with the terms hereof and the reservation and issuance of the New Warrant Shares in
accordance with the terms of the New Warrant). The execution and delivery of the Exchange Documents by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby, including, without limitation, the issuance of the New Primary
Securities in accordance with the terms hereof and the reservation and issuance of the New Warrant Shares in accordance with the
terms of the New Warrant, has been duly authorized by the Company’s Board of Directors and no further filing, consent, or
authorization is required by the Company, its Board of Directors or its stockholders. This Agreement and the other Exchange Documents
have been duly executed and delivered by the Company, and constitute the legal, valid and binding obligations of the Company,
enforceable against the Company in accordance with their respective terms, except as such enforceability may be limited by general
principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to,
or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as rights to indemnification
and to contribution may be limited by federal or state securities laws.


 


(c)
No Conflicts. The execution, delivery and performance of the Exchange Documents by the Company and the consummation by
the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the New Primary
Securities in accordance with the terms hereof and the reservation and issuance of the New Warrant Shares in accordance with the
terms of the New Warrant, as applicable) will not (i) result in a violation of the Articles of Incorporation (as defined below)
or any other organizational documents of the Company or any of its Subsidiaries, any capital stock of the Company or any of its
Subsidiaries or Bylaws (as defined below) of the Company or any of its Subsidiaries, (ii) conflict with, or constitute a default
(or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries
is a party, or (iii) to the Knowledge of the Company, result in a violation of any law, rule, regulation, order, judgment or decree
(including foreign, federal and state securities laws and regulations and the rules and regulations of the Nasdaq Capital Market
(the “Principal Market”) and including all applicable federal laws, rules and regulations) applicable to the
Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected.
For purposes of this Agreement, the term “Knowledge of the Company” or any other similar knowledge qualification,
means the actual or constructive knowledge of any director or officer of the Company, after due inquiry.


 




    	5



     


    




 


(d)
No Consents. Neither the Company nor any Subsidiary is required to obtain any consent from, authorization or order of,
or make any filing or registration with the Securities and Exchange Commission (the “SEC”) or state securities
agencies, filing of UCC-1 financing statements and approval by the Principal Market of a listing of additional shares application
in respect of the New Shares as required by Section 7 hereof), any court, governmental agency or any regulatory or self-regulatory
agency or any other Person in order for it to execute, deliver or perform any of its respective obligations under or contemplated
by this Agreement and the Exchange Documents, in each case, in accordance with the terms hereof or thereof. All consents, authorizations,
orders, filings and registrations which the Company or any Subsidiary is required to obtain pursuant to the preceding sentence
have been obtained or effected on or prior to the date hereof, and neither the Company nor any of its Subsidiaries are aware of
any facts or circumstances which might prevent the Company or any of its Subsidiaries from obtaining or effecting any of the registration,
application or filings contemplated by the Exchange Documents. Except as disclosed in the SEC Documents (as defined in Section
5(h) below), the Company is not in violation of the requirements of the Principal Market and has no knowledge of any facts or
circumstances which would reasonably lead to delisting or suspension of the Common Stock in the foreseeable future.


 


(e)
Securities Law Exemptions. Assuming the accuracy of the representations and warranties of the Holder contained herein,
the offer and issuance by the Company of the New Securities is exempt from registration under the 1933 Act pursuant to the exemption
provided by Rule 3(a)(9) thereof. Neither the Company nor any of its Affiliates nor any person acting on behalf of or for the
benefit of any of the foregoing, has paid or given, or agreed to pay or give, directly or indirectly, any commission or other
remuneration (within the meaning of Section 3(a)(9) of the 1933 Act and the rules and regulations of the SEC promulgated thereunder)
for soliciting the Exchange.


 


(f)
Issuance of New Securities. The issuance of the New Preferred Shares and the New Common Shares are duly authorized and,
upon issuance in accordance with the terms of this Agreement, the New Preferred Shares and the New Common Shares shall be validly
issued, fully paid and non-assessable and free from all preemptive or similar rights, mortgages, defects, claims, liens, pledges,
charges, taxes, rights of first refusal, encumbrances, security interests and other encumbrances (collectively “Encumbrances”)
with respect to the issue thereof. The New Warrant, when issued, shall be a binding and enforceable obligation of the Company
under the laws of the state of Nevada. The Company has reserved a sufficient number of Common Stock issuable up on the exercise
of the New Warrant and when the New Warrant Shares are issued accordance with the New Warrant, the New Warrant Shares, when issued,
will be validly issued, fully paid and nonassessable and free from all preemptive or similar rights or Liens with respect to the
issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock.


 




    	6



     


    




 


(g)
Transfer Taxes. On the date hereof, all share transfer or other taxes (other than income or similar taxes) which are required
to be paid in connection with the issuance of the New Securities to be exchanged with the Holder hereunder will be, or will have
been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will have been complied with.


 


(h)
SEC Documents; Financial Statements. As of the Effective Time, the Company has met all of its filing requirements of periodic
reports under Section 13 or Section 15(d) of Securities Exchange Act of 1934, as amended (the “1934 Act”) (all
of the foregoing filed prior to the date hereof, including without limitation, Current Reports on Form 8-K filed by the Company
with the SEC whether required to be filed or not (but excluding Item 7.01 thereunder), and all exhibits and appendices included
therein (other than Exhibits 99.1 to Form 8-K) and financial statements, notes and schedules thereto and documents incorporated
by reference therein being hereinafter referred to as the “SEC Documents”). Upon request by the Holder, the
Company has delivered or has made available to the Holder or its representatives true, correct and complete copies of each of
the SEC Documents not available on the EDGAR system. As of their respective dates, the SEC Documents complied in all material
respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the
SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading. As of their respective dates, the financial statements
of the Company included in the SEC Documents complied in all material respects with applicable accounting requirements and the
published rules and regulations of the SEC with respect thereto as in effect as of the time of filing. Such financial statements
have been prepared in accordance with generally accepted accounting principles (“GAAP”), consistently applied,
during the periods involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii)
in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements)
and fairly present in all material respects the financial position of the Company as of the dates thereof and the results of its
operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments
which will not be material, either individually or in the aggregate). No other information provided by or on behalf of the Company
to the Holder which is not included in the SEC Documents (including, without limitation, information in the disclosure schedules
to this Agreement) contains any untrue statement of a material fact or omits to state any material fact necessary in order to
make the statements therein not misleading, in the light of the circumstance under which they are or were made. The Company is
not currently contemplating to amend or restate any of the financial statements (including, without limitation, any notes or any
letter of the independent accountants of the Company with respect thereto) included in the SEC Documents (the “Financial
Statements”), nor is the Company currently aware of facts or circumstances which would require the Company to amend
or restate any of the Financial Statements, in each case, in order for any of the Financials Statements to be in compliance with
GAAP and the rules and regulations of the SEC. The Company has not been informed by its independent accountants that they recommend
that the Company amend or restate any of the Financial Statements or that there is any need for the Company to amend or restate
any of the Financial Statements.


 




    	7



     


    




 


(i)
Absence of Certain Changes. Except as set forth in the SEC Documents, since the date of the Company’s most recent
audited financial statements contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31,
2019, there has been no material adverse change and no material adverse development in the business, assets, liabilities, properties,
operations (including results thereof), condition (financial or otherwise) or prospects of the Company or any of its Subsidiaries.
Since the date of the Company’s most recent audited financial statements contained in the Company’s Annual Report
on Form 10-K for the fiscal year ended December 31, 2019, neither the Company nor any of its Subsidiaries has (i) declared or
paid any dividends, (ii) sold any assets, individually or in the aggregate, outside of the ordinary course of business or (iii)
except as disclosed in the SEC Documents, made any capital expenditures, individually or in the aggregate, outside of the ordinary
course of business. Neither the Company nor any of its Subsidiaries has taken any steps to seek protection pursuant to any law
or statute relating to bankruptcy, insolvency, reorganization, receivership, liquidation or winding up, nor does the Company or
any Subsidiary have any knowledge or reason to believe that any of their respective creditors intend to initiate involuntary bankruptcy
proceedings or any actual knowledge of any fact which would reasonably lead a creditor to do so. The Company and its Subsidiaries,
individually and on a consolidated basis, are not as of the date hereof, and after giving effect to the transactions contemplated
hereby to occur on the date hereof, will not be Insolvent (as defined below). For the purpose of this Agreement (x) “Insolvent”
means, (i) with respect to the Company and its Subsidiaries, on a consolidated basis, (A) the present fair saleable value of the
Company’s and its Subsidiaries’ assets is less than the amount required to pay the Company’s and its Subsidiaries’
total Indebtedness (as defined below), (B) the Company and its Subsidiaries are unable to pay their debts and liabilities, subordinated,
contingent or otherwise, as such debts and liabilities become absolute and matured or (C) the Company and its Subsidiaries intend
to incur or believe that they will incur debts that would be beyond their ability to pay as such debts mature; and (ii) with respect
to the Company and each Subsidiary, individually, (A) the present fair saleable value of the Company’s or such Subsidiary’s
(as the case may be) assets is less than the amount required to pay its respective total Indebtedness, (B) the Company or such
Subsidiary (as the case may be) is unable to pay its respective debts and liabilities, subordinated, contingent or otherwise,
as such debts and liabilities become absolute and matured or (C) the Company or such Subsidiary (as the case may be) intends to
incur or believes that it will incur debts that would be beyond its respective ability to pay as such debts mature; (y) “Indebtedness”
of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed
as the deferred purchase price of property or services (including, without limitation, “capital leases” in accordance
with GAAP) (other than trade payables entered into in the ordinary course of business consistent with past practice), (C) all
reimbursement or payment obligations with respect to letters of credit, surety bonds and other similar instruments, (D) all obligations
evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred in connection with the
acquisition of property, assets or businesses, (E) all indebtedness created or arising under any conditional sale or other title
retention agreement, or incurred as financing, in either case with respect to any property or assets acquired with the proceeds
of such indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event of default are
limited to repossession or sale of such property), (F) all monetary obligations under any leasing or similar arrangement which,
in connection with GAAP, consistently applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness
referred to in clauses (A) through (F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent
or otherwise, to be secured by) any Lien upon or in any property or assets (including accounts and contract rights) owned by any
Person, even though the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness,
and (H) all Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A)
through (G) above; and (z) “Contingent Obligation” means, as to any Person, any direct or indirect liability,
contingent or otherwise, of that Person with respect to any Indebtedness, lease, dividend or other obligation of another Person
if the primary purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance
to the obligee of such liability that such liability will be paid or discharged, or that any agreements relating thereto will
be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with respect thereto.


 








(j)
No Undisclosed Events, Liabilities, Developments or Circumstances. Except as set forth in the SEC Documents, no event,
liability, development or circumstance has occurred or exists, or is reasonably expected to exist or occur with respect to the
Company, any of its Subsidiaries or any of their respective businesses, properties, liabilities, prospects, operations (including
results thereof) or condition (financial or otherwise), that (i) would be required to be disclosed by the Company under applicable
securities laws on a registration statement on Form S-1 filed with the SEC relating to an issuance and sale by the Company of
its Common Stock and which has not been publicly announced, (ii) would reasonably expected to have a material adverse effect on
the Holder’s investment hereunder or (iii) would reasonably be expected to have a Material Adverse Effect on the Company
..


 






    	8



     


    




 


(k)
Conduct of Business; Regulatory Permits. Neither the Company nor any of its Subsidiaries is in violation of any term of
or in default under its Articles of Incorporation, any certificate of designation, preferences or rights of any other outstanding
series of Preferred Stock of the Company or any of its Subsidiaries or Bylaws or their organizational charter, certificate of
formation, memorandum of association, articles of association, Articles of Incorporation or bylaws, respectively. Except as set
forth in the SEC Documents, neither the Company nor any of its Subsidiaries is in violation of any judgment, decree or order or
any statute, ordinance, rule or regulation applicable to the Company or any of its Subsidiaries, and neither the Company nor any
of its Subsidiaries will conduct its business in violation of any of the foregoing, except in all cases for possible violations
which could not, individually or in the aggregate, have a Material Adverse Effect. Except as set forth in the SEC Documents, without
limiting the generality of the foregoing, the Company is not in violation of any of the rules, regulations or requirements of
the Principal Market and has no knowledge of any facts or circumstances that could reasonably lead to delisting or suspension
of the Common Stock by the Principal Market in the foreseeable future. Except as set forth in the SEC Documents, during the two
years prior to the date hereof, (i) the Common Stock has been listed or designated for quotation on the Principal Market, (ii)
trading in the Common Stock has not been suspended by the SEC or the Principal Market and (iii) the Company has received no communication,
written or oral, from the SEC or the Principal Market regarding the suspension or delisting of the Common Stock from the Principal
Market. The Company and each of its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such certificates,
authorizations or permits would not have, individually or in the aggregate, a Material Adverse Effect, and neither the Company
nor any such Subsidiary has received any notice of proceedings relating to the revocation or modification of any such certificate,
authorization or permit. There is no agreement, commitment, judgment, injunction, order or decree binding upon the Company or
any of its Subsidiaries or to which the Company or any of its Subsidiaries is a party which has or would reasonably be expected
to have the effect of prohibiting or materially impairing any business practice of the Company or any of its Subsidiaries, any
acquisition of property by the Company or any of its Subsidiaries or the conduct of business by the Company or any of its Subsidiaries
as currently conducted other than such effects, individually or in the aggregate, which have not had and would not reasonably
be expected to have a Material Adverse Effect on the Company or any of its Subsidiaries.


 








(l)
Transactions With Affiliates. Except as set forth in the SEC Documents, no current or former employee, partner, director,
officer or stockholder (direct or indirect) of the Company or its Subsidiaries, or any associate, or, to the knowledge of the
Company, any affiliate of any thereof, or any relative with a relationship no more remote than first cousin of any of the foregoing,
is presently, or has ever been, (i) a party to any transaction with the Company or its Subsidiaries (including any contract, agreement
or other arrangement providing for the furnishing of services by, or rental of real or personal property from, or otherwise requiring
payments to, any such director, officer or stockholder or such associate or affiliate or relative Subsidiaries (other than for
ordinary course services as employees, consultants, officers or directors of the Company or any of its Subsidiaries)) or (ii)
the direct or indirect owner of an interest in any corporation, firm, association or business organization which is a competitor,
supplier or customer of the Company or its Subsidiaries (except for a passive investment (direct or indirect) in less than 5%
of the common stock of a company whose securities are traded on or quoted through an Eligible Market), nor does any such Person
receive income from any source other than the Company or its Subsidiaries which relates to the business of the Company or its
Subsidiaries or should properly accrue to the Company or its Subsidiaries. Except as set forth in the SEC Documents, no employee,
officer, stockholder or director of the Company or any of its Subsidiaries or member of his or her immediate family is indebted
to the Company or its Subsidiaries, as the case may be, nor is the Company or any of its Subsidiaries indebted (or committed to
make loans or extend or guarantee credit) to any of them, other than (i) for payment of salary for services rendered, (ii) reimbursement
for reasonable expenses incurred on behalf of the Company, and (iii) for other standard employee benefits made generally available
to all employees or executives (including stock option agreements outstanding under any stock option plan approved by the Board
of Directors of the Company).


 




    	9



     


    

 


(m)
Equity Capitalization.


 


(i)
Definitions:


 


(1)
“Common Stock” means (x) the Company’s shares of common stock, $0.0001 par value per share, and (y) any
capital stock into which such common stock shall have been changed or any share capital resulting from a reclassification of such
Common Stock.


 


(2)
“Preferred Stock” means (x) the Company’s blank check preferred stock, $0.0001 par value per share, the
terms of which may be designated by the board of directors of the Company in a certificate of designation and (y) any capital
stock into which such Preferred Stock shall have been changed or any share capital resulting from a reclassification of such Preferred
Stock (other than a conversion of such preferred stock into Common Stock in accordance with the terms of such certificate of designations).


 


(ii)
Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of
(A) 200,000,000 shares of Common Stock, of which, 38,433,933 are issued and outstanding as of the date hereof and 22,122,295 are
reserved for issuance pursuant to Convertible Securities (as defined below), in each case exercisable or exchangeable for, or
convertible into, shares of Common Stock, excluding shares of Common Stock issuable upon the conversion of the Existing Notes
and the exercise of the Existing Warrants and an aggregate of 3,352,116 shares of Common Stock issuable pursuant to awards available
for grant under the Company’s 2016 Equity Incentive Plan and 2018 Equity Incentive Plan, and (B) 5 million shares of Preferred
Stock, of which (i) none have been designated as Series A Preferred Stock; (ii) 1,000,000 have designated as Series B Convertible
Preferred Stock, none of which are issued and outstanding, (iii) 4,268 have been designated as Series C Convertible Preferred
Stock, none of which are issued and outstanding, (iv) 5,775 have designated as Series D Convertible Preferred Stock, none of which
none are issued and outstanding, (v) 15 shares have been designated as Series E Preferred Stock, none of which are issued and
outstanding prior to the Effective Time. No shares of Common Stock are held in the treasury of the Company. “Convertible
Securities” means any outstanding capital stock or other security of the Company or any of its Subsidiaries that is
at any time and under any circumstances directly or indirectly convertible into, exercisable or exchangeable for, or which otherwise
entitles the holder thereof to acquire, any capital stock or other security of the Company (including, without limitation, Common
Stock) or any of its Subsidiaries.


 




    	10



     


    




 


(iii)
Valid Issuance; Available Shares; Affiliates. All of such outstanding shares of Common Stock are duly authorized and have
been, or upon issuance will be, validly issued and are fully paid and nonassessable. As of the date hereof, an aggregate of 256,534
shares of Common Stock are owned by Persons who are “affiliates” (as defined in Rule 405 of the 1933 Act and calculated
based on the assumption that only officers, directors and holders of at least 10% of the Company’s issued and outstanding
Common Stock are “affiliates” without conceding that any such Persons are “affiliates” for purposes of
federal securities laws) of the Company or any of its Subsidiaries.


 


(iv)
Existing Securities; Obligations. Except as disclosed in the SEC Documents: (A) none of the Company’s or any Subsidiary’s
shares, interests or capital stock is subject to any Encumbrances; (B) there are no outstanding options, warrants, scrip, rights
to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable
or exchangeable for, any shares, interests or capital stock of the Company or any of its Subsidiaries, or contracts, commitments,
understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional shares,
interests or capital stock of the Company or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls
or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable
for, any shares, interests or capital stock of the Company or any of its Subsidiaries; (C) there are no agreements or arrangements
under which the Company or any of its Subsidiaries is obligated to register the sale of any of their securities under the 1933
Act; (D) there are no outstanding securities or instruments of the Company or any of its Subsidiaries which contain any redemption
or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any of
its Subsidiaries is or may become bound to redeem a security of the Company or any of its Subsidiaries; (E) there are no securities
or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the New Securities; and
(F) neither the Company nor any Subsidiary has any stock appreciation rights or “phantom stock” plans or agreements
or any similar plan or agreement.


 


(v)
Organizational Documents. The Company has furnished or has made available to the Holder by filing on the SEC EDGAR system,
true, correct and complete copies of the Company’s Articles of Incorporation, as amended and as in effect on the date hereof
(the “Articles of Incorporation”), the Company’s bylaws, as amended and as in effect on the date hereof
(the “Bylaws”), and the terms of all Convertible Securities and the material rights of the holders thereof
in respect thereto.


 




    	11



     


    




 


(n)
Indebtedness and Other Contracts. Neither the Company nor any of its Subsidiaries, (i) except as disclosed in the SEC Documents,
has any outstanding debt securities, notes, credit agreements, credit facilities or other agreements, documents or instruments
evidencing Indebtedness of the Company or any of its Subsidiaries or by which the Company or any of its Subsidiaries is or may
become bound, (ii) is a party to any contract, agreement or instrument, except as disclosed in the SEC Documents, the violation
of which, or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably be expected
to result in a Material Adverse Effect, (iii) has any financing statements securing obligations in any amounts filed in connection
with the Company or any of its Subsidiaries, except as disclosed in the SEC Documents; (iv) is in violation of any term of, or
in default under, any contract, agreement or instrument relating to any Indebtedness, except where such violations and defaults
would not result, individually or in the aggregate, in a Material Adverse Effect, or (v) is a party to any contract, agreement
or instrument relating to any Indebtedness, the performance of which, in the judgment of the Company’s officers, has or
is expected to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries have any liabilities or obligations
required to be disclosed in the SEC Documents which are not so disclosed in the SEC Documents, other than those incurred in the
ordinary course of the Company’s or its Subsidiaries’ respective businesses and which, individually or in the aggregate,
do not or could not have a Material Adverse Effect.


 


(o)
Litigation. Except as otherwise disclosed by the Company in its SEC Documents, there is no action, suit, arbitration, proceeding,
inquiry or investigation before or by the Principal Market, any court, public board, other Governmental Entity, self-regulatory
organization or body pending or, to the Knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries,
the Common Stock or any of the Company’s or its Subsidiaries’ officers or directors that would reasonably be expected
to have a Material Adverse Effect on the Company or its Subsidiaries, whether of a civil or criminal nature or otherwise, in their
capacities as such, except as disclosed in the SEC Documents. No director, officer or employee of the Company or any of its Subsidiaries
has willfully violated 18 U.S.C. §1519 or engaged in spoliation in reasonable anticipation of litigation. Without limitation
of the foregoing, there has not been, and to the Knowledge of the Company, there is not pending or contemplated, any investigation
by the SEC involving the Company, any of its Subsidiaries or any current or former director or officer of the Company or any of
its Subsidiaries. The SEC has not issued any stop order or other order suspending the effectiveness of any registration statement
filed by the Company under the 1933 Act or the 1934 Act. Neither the Company nor any of its Subsidiaries is subject to any order,
writ, judgment, injunction, decree, determination or award of any Governmental Entity.


 






    	12



     


    




 


(p)
Disclosure. The Company confirms that neither it nor any other Person acting on its behalf has provided the Holder or its
agents or counsel with any information that constitutes or would reasonably be expected to constitute material, non-public information
concerning the Company or any of its Subsidiaries, other than the existence of the transactions contemplated by this Agreement
and the other Exchange Documents. The Company understands and confirms that the Holder will rely on the foregoing representations
in effecting transactions in securities of the Company. All disclosure provided to the Holder regarding the Company and its Subsidiaries,
their businesses and the transactions contemplated hereby, including the schedules to this Agreement, furnished by or on behalf
of the Company or any of its Subsidiaries is true and correct and does not contain any untrue statement of a material fact or
omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under
which they were made, not misleading. Each press release issued by the Company or any of its Subsidiaries during the twelve (12)
months preceding the date of this Agreement did not at the time of release contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light
of the circumstances under which they are made, not misleading. No event or circumstance has occurred or information exists with
respect to the Company or any of its Subsidiaries or its or their business, properties, liabilities, prospects, operations (including
results thereof) or conditions (financial or otherwise), which, under applicable law, rule or regulation, requires public disclosure
at or before the date hereof or announcement by the Company but which has not been so publicly announced or disclosed.











 


6.
Holder’s Representations and Warranties. As a material inducement to the Company to enter into this Agreement
and consummate the Transactions, the Holder represents, warrants and covenants with and to the Company as of the date hereof and
the Effective Time, as follows:


 


(a)
Reliance on Exemptions. The Holder understands that the New Securities are being offered and exchanged in reliance on specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying
in part upon the truth and accuracy of, and the Holder’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Holder set forth herein and in the Exchange Documents in order to determine the availability of such
exemptions and the eligibility of the Holder to acquire the New Securities.


 


(b)
No Governmental Review. The Holder understands that no United States federal or state agency or any other government or
governmental agency has passed on or made any recommendation or endorsement of the New Securities or the fairness or suitability
of the investment in the New Securities nor have such authorities passed upon or endorsed the merits of the offering of the New
Securities.


 


(c)
Validity; Enforcement. This Agreement and the Exchange Documents to which the Holder is a party have been duly and validly
authorized, executed and delivered on behalf of the Holder and shall constitute the legal, valid and binding obligations of the
Holder enforceable against the Holder in accordance with their respective terms, except as such enforceability may be limited
by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar
laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.


 




    	13



     


    




 


(d)
No Conflicts. The execution, delivery and performance by the Holder of this Agreement and the Exchange Documents to which
the Holder is a party, and the consummation by the Holder of the transactions contemplated hereby and thereby will not (i) result
in a violation of the organizational documents of the Holder or (ii) conflict with, or constitute a default (or an event which
with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture or instrument to which the Holder is a party, or (iii) result in a violation of any
law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable to the Holder, except
in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations which would not, individually
or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the Holder to perform its obligations
hereunder.


 


(e)
Investment Risk; Sophistication. The Holder is acquiring the New Securities hereunder in the ordinary course of its business.
The Holder has such knowledge, sophistication, and experience in business and financial matters so as to be capable of evaluation
of the merits and risks of the prospective investment in the New Securities, and has so evaluated the merits and risk of such
investment. The Holder is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the
1933 Act. Investor is acquiring the New Securities solely for its own account for investment purposes and not with a view to,
or for offer or sale in connection with, any distribution thereof. Investor acknowledges that the New Preferred Shares, New Common
Shares, New Warrant and, when issued, the New Warrant Shares are not registered under the 1933 Act, or any state securities laws,
and that such securities may not be transferred or sold except pursuant to the registration provisions of the 1933 Act or pursuant
to an applicable exemption therefrom and subject to state securities laws and regulations, as applicable.


 


(f)
Ownership of Existing Securities. The Holder owns the Existing Securities free and clear of any Encumbrances (other than
the obligations pursuant to this Agreement and applicable securities laws).


 


7.
Disclosure of Transaction. The Company shall, on or before 8:30 a.m., New York City Time, on or prior to the first
business day after the date of this Agreement, file a Current Report on Form 8-K describing the terms of the transactions contemplated
hereby in the form required by the 1934 Act and attaching this Agreement, New Certificate of Designation and New Warrant as exhibits
to such filing (excluding schedules, the “8-K Filing”). From and after the filing of the 8-K Filing, the Company
shall have disclosed all material, non-public information (if any) provided up to such time to the Holder by the Company or any
of its Subsidiaries or any of their respective officers, directors, employees or agents. In addition, upon the filing of the 8-K
Filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement with respect
to the transactions contemplated by the Exchange Documents or as otherwise disclosed in the 8-K Filing, whether written or oral,
between the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents,
on the one hand, and any of the Holder or any of their affiliates, on the other hand, shall terminate. Neither the Company, its
Subsidiaries nor the Holder shall issue any press releases or any other public statements with respect to the transactions contemplated
hereby; provided, however, the Company shall be entitled, without the prior approval of the Holder,
to issue a press release or make such other public disclosure with respect to such transactions (i) in substantial conformity
with the 8-K Filing and contemporaneously therewith or (ii) as is required by applicable law and regulations (provided that in
the case of clause (i) the Holder shall be consulted by the Company in connection with any such press release or other public
disclosure prior to its release). Without the prior written consent of the Holder (which may be granted or withheld in the Holder’s
sole discretion), except as required by applicable law, the Company shall not (and shall cause each of its Subsidiaries and affiliates
to not) disclose the name of the Holder in any filing, announcement, release or otherwise.


 




    	14



     


    




 


8.
No Integration. None of the Company, its Subsidiaries, any of their affiliates, or any Person acting on their behalf
shall, directly or indirectly, make any offers or sales of any security (as defined in the 1933 Act) or solicit any offers to
buy any security or take any other actions, under circumstances that would require registration of any of the New Securities under
the 1933 Act or cause this offering to be integrated with such offering or any prior offerings by the Company for purposes of
Regulation D under the 1933 Act.


 


9.
Listing. The Company shall promptly secure the listing or designation for quotation (as applicable) of all of the
New Shares upon the Principal Market (subject to official notice of issuance) and shall maintain such listing of all the New Shares
from time to time issuable under the terms of the Exchange Documents. The Company shall use its best efforts to maintain the Common
Stock’s listing on the Principal Market. Neither the Company nor any of its Subsidiaries shall take any action which would
be reasonably expected to result in the delisting or suspension of the Common Stock on the Principal Market. The Company shall
pay all fees and expenses in connection with satisfying its obligations under this Section 9.


 


10.
Fees. The Company shall reimburse Kelley Drye & Warren, LLP (counsel to the lead Holder) in an aggregate non-accountable
amount of $20,000 (the “Legal Fee Amount”) for costs and expenses incurred by it in connection with drafting
and negotiation of the Exchange Documents. Each party to this Agreement shall bear its own expenses in connection with the structuring,
documentation, negotiation and closing of the transactions contemplated hereby, except as provided in the previous sentence and
except that the Company shall be responsible for the payment of any placement agent’s fees, financial advisory fees, transfer
agent fees, Depository Trust Company (“DTC”) fees relating to or arising out of the transactions contemplated
hereby.


 


11.
Holding Period. For the purposes of Rule 144, the Company acknowledges that the holding period of the New Primary
Securities (and upon exercise of the New Warrant (assuming a cashless exercise thereof, the New Warrant Shares) is expected to
be tacked onto the holding period of the Existing Securities the Company agrees not to take a position contrary to this Section
11. The Company acknowledges and agrees that (assuming the Holder is not an “affiliate” of the Company as that term
is defined in the 1933 Act) (i) the New Primary Securities (and upon exercise of the New Warrant (assuming a cashless exercise
thereof, the New Warrant Shares) are eligible to be resold pursuant to Rule 144, (ii) the Company is not aware of any event reasonably
likely to occur that would reasonably be expected to result in the New Primary Securities (and upon exercise of the New Warrant
(assuming a cashless exercise thereof, the New Warrant Shares) becoming ineligible to be resold by the Holder pursuant to Rule
144 and (iii) in connection with any resale of the New Primary Securities (and upon exercise of the New Warrant (assuming a cashless
exercise thereof, the New Warrant Shares) pursuant to Rule 144, the Holder shall solely be required to provide reasonable assurances
that such applicable New Primary Securities (and upon exercise of the New Warrant (assuming a cashless exercise thereof, the New
Warrant Shares) are eligible for resale, assignment or transfer under Rule 144, which shall not include an opinion of Holder’s
counsel. The Company shall be responsible for any transfer agent fees or DTC fees or legal fees of the Company’s counsel
with respect to the removal of legends, if any, or issuance of any New Primary Securities (and upon exercise of the New Warrant
(assuming a cashless exercise thereof, the New Warrant Shares).


 




    	15



     


    




 


12.
Blue Sky. The Company shall make all filings and reports relating to the Exchange required under applicable securities
or “Blue Sky” laws of the states of the United States following the date hereof, if any.


 


13.
Pre-Effective Time Sales. Notwithstanding anything herein to the contrary, if at any time on or after the time of
execution of this Agreement, through and including the Effective Time (the “Pre-Settlement Period”), the Holder
sells to any Person all, or any portion, of any New Common Shares to be issued hereunder to the Holder in the Exchange (collectively,
the “Pre-Settlement Shares”), such portion of the Exchange with respect to such Pre-Settlement Shares shall
be deemed to have occurred as of the time of such sale; and provided further that the Company hereby acknowledges and agrees that
the forgoing shall not constitute a representation or covenant by the Holder as to whether or not during the Pre-Settlement Period
the Holder shall sell any New Common Shares to any Person and that any such decision to sell any New Common Shares by the Holder
shall be made, in the sole discretion of the Holder, at the time the Holder elects to effect any such sale, if any.


 


14.
Most Favored Nation. The Company hereby represents and warrants as of the date hereof and covenants and agrees that
none of the terms offered to any Person with respect to any amendment, modification, waiver or exchange of any warrant to purchase
Common Stock (or other similar instrument), including, without limitation with respect to any consent, release, amendment, settlement,
or waiver relating thereto (each an “Settlement Document”), is or will be more favorable to such Person (other
than any reimbursement of legal fees) than those of the Holder and this Agreement. If, and whenever on or after the date hereof,
the Company enters into a Settlement Document, then (i) the Company shall provide notice thereof to the Holder promptly following
the occurrence thereof and (ii) the terms and conditions of this Agreement shall be, without any further action by the Holder
or the Company, automatically amended and modified in an economically and legally equivalent manner such that the Holder shall
receive the benefit of the more favorable terms and/or conditions (as the case may be) set forth in such Settlement Document,
provided that upon written notice to the Company at any time the Holder may elect not to accept the benefit of any such amended
or modified term or condition, in which event the term or condition contained in this Agreement shall apply to the Holder as it
was in effect immediately prior to such amendment or modification as if such amendment or modification never occurred with respect
to the Holder. The provisions of this Section 14 shall apply similarly and equally to each Settlement Document.


 




    	16



     


    




 


15.
Independent Nature of Holder’s Obligations and Rights. The obligations of the Holder under this Agreement
are several and not joint with the obligations of any other holder of securities of the Company (each, an “Other Holder”),
and the Holder shall not be responsible in any way for the performance of the obligations of any Other Holder under any other
agreement by and between the Company and any Other Holder (each, an “Other Agreement”). Nothing contained herein
or in any Other Agreement, and no action taken by the Holder pursuant hereto, shall be deemed to constitute the Holder and Other
Holders as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Holder
and Other Holders are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated
by this Agreement or any Other Agreement and the Company acknowledges that, to the best of its knowledge, the Holder and the Other
Holders are not acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement
or any Other Agreement. The Company and the Holder confirm that the Holder has independently participated in the negotiation of
the transactions contemplated hereby with the advice of its own counsel and advisors. The Holder shall be entitled to independently
protect and enforce its rights, including, without limitation, the rights arising out of this Agreement, and it shall not be necessary
for any Other Holder to be joined as an additional party in any proceeding for such purpose.


 


16.
Miscellaneous.


 


(a)
Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to
the benefit of and be binding upon the parties hereto and the respective successors and assigns of the parties. Nothing in this
Agreement, express or implied, is intended to confer upon any party, other than the parties hereto or their respective successors
and assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided
in this Agreement.


 


(b)
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law
or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state or federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any
such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or
proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY
WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION
WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.


 




    	17



     


    




 


(c)
Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement.


 


(d)
Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this
Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon
delivery, when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on
file by the sending party) or by electronic mail; or (iii) one Trading Day after deposit with an overnight courier service, in
each case properly addressed to the party to receive the same. The addresses, facsimile numbers and e-mail addresses for such
communications shall be as set forth on the signature pages attached hereto or to such other address, facsimile number and/or
e-mail address and/or to the attention of such other Person as the recipient party has specified by written notice given to each
other party five (5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient
of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s facsimile
machine or e-mail containing the time, date, recipient facsimile number and an image of the first page of such transmission or
(C) provided by an overnight courier service shall be rebuttable evidence of personal service, receipt by facsimile or receipt
from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.


 


(e)
Broker and Finder’s Fees. Each party represents that it neither is nor will be obligated for any finders’ fee
or broker commission in connection with this transaction.


 


(f)
Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may
be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent
of the Company and the Holder, or successor and assignee as provided under this Agreement.


 


(g)
Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision
shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded
and shall be enforceable in accordance with its terms so long as this Agreement as so modified continues to express, without material
change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties
or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in
good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect
of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).


 




    	18



     


    




 


(h)
Entire Agreement. This Agreement together with the other Exchange Documents, represents the entire agreement and understandings
between the parties concerning the Transactions and the other matters described herein and therein and supersedes and replaces
any and all prior agreements and understandings solely with respect to the subject matter hereof and thereof. Except as expressly
set forth herein, nothing herein shall amend, modify or waive any term or condition of the other Exchange Documents.


 


(i)
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument.


 


(j)
Interpretation. Unless the context of this Agreement clearly requires otherwise, (i) references to the plural include the
singular, the singular the plural, the part the whole, (ii) references to any gender include all genders, (iii) “including”
has the inclusive meaning frequently identified with the phrase “but not limited to” and (iv) references to “hereunder”
or “herein” relate to this Agreement.


 


(k)
No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.


 


(l)
Survival. The representations, warranties and covenants of the Company and the Holder contained herein shall survive the
consummation of the Transactions and the issuance and delivery of the New Securities.


 


(m)
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.


 


(n)
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to
express their mutual intent, and no rules of strict construction will be applied against any party.


 


[SIGNATURE
PAGE FOLLOWS]


 




    	19



     


    

 


IN
WITNESS WHEREOF, the Company and the Holder have each executed this Agreement as of the date set forth on the first page of
this Agreement.


 


	 	COMPANY:
	 	 
	 	TOUGHBUILT
    INDUSTRIES, INC.
	 	 	 
	 	By:	/s/
    Michael Panosian
	 	Name:
    	Michael
    Panosian 
	 	Title:
    	Chief
    Executive Officer 
	 	 	 
	 	Address:
	 	 	 
	 	25371
    Commercentre Drive, Suite 200
	 	Lake
    Forest, CA 92630





 


[EXHANGE
AGREEMENT SIGNATURE PAGE]


 




    	 



     


    

 


IN
WITNESS WHEREOF, the Holder and Company have executed this Agreement as of the date set forth on the first page of this Agreement.


 


	Aggregate Principal of Existing Series A Note to be exchanged:	 	HOLDER:
	 	 	
	$551,050	 	ALTO
    OPPORTUNITY MASTER FUND, SPC - SEGREGATED MASTER PORTFOLIO B
	 	 	 
	Aggregate Restricted Principal of Existing Series B Note to be redeemed:	 	 
		 	By:	/s/
    Waqas Khatri
	$1,480,000	 	Name:	Waqas Khatri 
		 	Title:  	Director



 


	Aggregate Unrestricted Principal of Existing Series
    B Note to be exchanged:	 	Address:	 
	 
	 	 	 
	$100,000	 	 	 
	 	 	 	 
	Aggregate Principal of Investor Note to be subject to Redemption
    Netting:	 	 	 
	 	 	 	 
	$1,480,000	 	 	 



 


	Aggregate
    Number of Shares of Common Stock issuable upon exercise of the Existing Warrants*:	 	DWAC
    Instructions:	 
	 
	 	 	 
	575,000	 	 	 
	 	 	 	 
	Aggregate Number
    of New Common Shares to be issued in the Exchange:	 	 	 
	 	 	 	 
	1,850,000	 	 	 
	 	 	 	 
	Aggregate Number
    of New Warrant Shares to be issued in the Exchange *:	 	Wire
    Instructions:	 
	 
	 	 	 
	575,000	 	 	 
	 	 	 	 
	Aggregate Number
    of New Preferred Shares to be issued in the Exchange:	 	 	 
	 	 	 	 
	9	 	 	 





 


*without
regard to any limitation on exercise set forth therein.


 


[EXHANGE
AGREEMENT SIGNATURE PAGE]